Chronic obstructive pulmonary disease (COPD) is the third most common cause of death in
the USA. In 2010, the cost of COPD in the USA was projected to be approximately US …

The impact of non-communicable diseases (NCDs) in populations extends beyond ill-health
and mortality with large financial consequences. To systematically review and meta-analyze …

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
worldwide. Age and smoking are common risk factors for COPD and other illnesses, often …

Chronic obstructive pulmonary disease (COPD) continues to be an important cause of
morbidity, mortality, and health-care costs worldwide. It is a global health issue, with …

Background: Patients with chronic obstructive pulmonary disease (COPD) often present with
severe acute exacerbations requiring hospital treatment. However, little is known about the …

Background Several COPD phenotypes have been described; the COPD-asthma overlap is
one of the most recognized. The aim of this study was to evaluate the prevalence of three …

Background: Improving a patient's ability to self-monitor and manage changes in chronic
obstructive pulmonary disease (COPD) symptoms may improve outcomes. Objective: To …

Pulmonary disease is common in patients with heart failure, through shared risk factors and
pathophysiological mechanisms. Adverse pulmonary vascular remodelling and chronic …

Background: Belonging to the group of expectorants, ambroxol is an active substance with a
long history that influences parameters considered to be the basis for the physiological …

The number of cost-of-illness (COI) studies has expanded considerably over time. One
outcome of this growth is that the reported COI estimates are inconsistent across studies …